US Stock MarketDetailed Quotes

Anavex Life Sciences (AVXL)

Watchlist
  • 3.400
  • +0.160+4.94%
Close Apr 16 16:00 ET
  • 3.300
  • -0.100-2.94%
Pre 06:22 ET
315.08MMarket Cap-7.39P/E (TTM)

Anavex Life Sciences (AVXL) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
9.09%131.75M
-22.40%102.58M
-22.40%102.58M
-27.09%101.16M
-16.94%115.77M
-15.99%120.78M
-12.47%132.19M
-12.47%132.19M
-10.37%138.76M
-9.18%139.39M
-Cash and cash equivalents
9.09%131.75M
-22.40%102.58M
-22.40%102.58M
-27.09%101.16M
-16.94%115.77M
-15.99%120.78M
-12.47%132.19M
-12.47%132.19M
-10.37%138.76M
-9.18%139.39M
Receivables
-66.99%844K
-66.97%809K
-66.97%809K
-52.33%820K
-82.40%666K
-27.95%2.56M
-9.60%2.45M
-9.60%2.45M
-20.56%1.72M
-20.11%3.79M
-Taxes receivable
-66.99%844K
-66.97%809K
-66.97%809K
-52.33%820K
-82.40%666K
-27.95%2.56M
-9.60%2.45M
-9.60%2.45M
-20.56%1.72M
-20.11%3.79M
Other current assets
-44.30%396K
-53.92%429K
-53.92%429K
-57.70%448K
-47.81%702K
-5.95%711K
42.57%931K
42.57%931K
27.96%1.06M
37.00%1.35M
Total current assets
7.21%132.99M
-23.42%103.82M
-23.42%103.82M
-27.63%102.43M
-18.94%117.14M
-16.23%124.04M
-12.19%135.57M
-12.19%135.57M
-10.31%141.54M
-9.22%144.52M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
7.21%132.99M
-23.42%103.82M
-23.42%103.82M
-27.63%102.43M
-18.94%117.14M
-16.23%124.04M
-12.19%135.57M
-12.19%135.57M
-10.31%141.54M
-9.22%144.52M
Liabilities
Current liabilities
Payables
-42.22%2.64M
-55.86%4.25M
-55.86%4.25M
92.41%6.74M
87.79%7M
6.41%4.57M
122.74%9.63M
122.74%9.63M
-15.65%3.5M
-40.69%3.73M
-accounts payable
-42.22%2.64M
-55.86%4.25M
-55.86%4.25M
92.41%6.74M
87.79%7M
6.41%4.57M
122.74%9.63M
122.74%9.63M
-15.65%3.5M
-40.69%3.73M
Current accrued expenses
-70.26%1.7M
-29.56%2.33M
-29.56%2.33M
-56.52%2.74M
71.65%7.36M
3.84%5.71M
-44.26%3.31M
-44.26%3.31M
25.24%6.3M
-18.39%4.29M
Current deferred liabilities
-2.90%805K
-4.39%805K
-4.39%805K
-12.21%805K
-9.60%829K
-9.60%829K
-8.18%842K
-8.18%842K
0.03%917K
0.03%917K
Current liabilities
-51.47%6.37M
-41.54%8.95M
-41.54%8.95M
-2.38%11.47M
81.85%17.38M
5.07%13.13M
22.10%15.3M
22.10%15.3M
6.32%11.75M
-31.83%9.56M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-51.47%6.37M
-41.54%8.95M
-41.54%8.95M
-2.38%11.47M
81.85%17.38M
5.07%13.13M
22.10%15.3M
22.10%15.3M
6.32%11.75M
-31.83%9.56M
Shareholders'equity
Share capital
9.41%93K
2.35%87K
2.35%87K
0.00%85K
1.19%85K
3.66%85K
3.66%85K
3.66%85K
4.43%85K
4.69%84K
-common stock
9.41%93K
2.35%87K
2.35%87K
0.00%85K
1.19%85K
3.66%85K
3.66%85K
3.66%85K
4.43%85K
4.69%84K
-Preferred stock
--0
----
----
--0
--0
----
----
----
----
----
Retained earnings
-11.47%-388.13M
-13.80%-382.45M
-13.80%-382.45M
-14.85%-372.62M
-15.10%-359.38M
-15.41%-348.18M
-14.67%-336.07M
-14.67%-336.07M
-14.68%-324.45M
-14.94%-312.24M
Paid-in capital
12.12%514.65M
4.60%477.23M
4.60%477.23M
2.04%463.49M
2.62%459.05M
4.99%459.01M
4.92%456.25M
4.92%456.25M
5.74%454.24M
7.35%447.35M
Other equity interest
----
----
----
----
----
----
----
----
---89K
---234K
Total stockholders'equity
14.16%126.62M
-21.12%94.87M
-21.12%94.87M
-29.91%90.96M
-26.08%99.76M
-18.19%110.92M
-15.22%120.26M
-15.22%120.26M
-11.57%129.78M
-7.03%134.96M
Total equity
14.16%126.62M
-21.12%94.87M
-21.12%94.87M
-29.91%90.96M
-26.08%99.76M
-18.19%110.92M
-15.22%120.26M
-15.22%120.26M
-11.57%129.78M
-7.03%134.96M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 9.09%131.75M-22.40%102.58M-22.40%102.58M-27.09%101.16M-16.94%115.77M-15.99%120.78M-12.47%132.19M-12.47%132.19M-10.37%138.76M-9.18%139.39M
-Cash and cash equivalents 9.09%131.75M-22.40%102.58M-22.40%102.58M-27.09%101.16M-16.94%115.77M-15.99%120.78M-12.47%132.19M-12.47%132.19M-10.37%138.76M-9.18%139.39M
Receivables -66.99%844K-66.97%809K-66.97%809K-52.33%820K-82.40%666K-27.95%2.56M-9.60%2.45M-9.60%2.45M-20.56%1.72M-20.11%3.79M
-Taxes receivable -66.99%844K-66.97%809K-66.97%809K-52.33%820K-82.40%666K-27.95%2.56M-9.60%2.45M-9.60%2.45M-20.56%1.72M-20.11%3.79M
Other current assets -44.30%396K-53.92%429K-53.92%429K-57.70%448K-47.81%702K-5.95%711K42.57%931K42.57%931K27.96%1.06M37.00%1.35M
Total current assets 7.21%132.99M-23.42%103.82M-23.42%103.82M-27.63%102.43M-18.94%117.14M-16.23%124.04M-12.19%135.57M-12.19%135.57M-10.31%141.54M-9.22%144.52M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets 7.21%132.99M-23.42%103.82M-23.42%103.82M-27.63%102.43M-18.94%117.14M-16.23%124.04M-12.19%135.57M-12.19%135.57M-10.31%141.54M-9.22%144.52M
Liabilities
Current liabilities
Payables -42.22%2.64M-55.86%4.25M-55.86%4.25M92.41%6.74M87.79%7M6.41%4.57M122.74%9.63M122.74%9.63M-15.65%3.5M-40.69%3.73M
-accounts payable -42.22%2.64M-55.86%4.25M-55.86%4.25M92.41%6.74M87.79%7M6.41%4.57M122.74%9.63M122.74%9.63M-15.65%3.5M-40.69%3.73M
Current accrued expenses -70.26%1.7M-29.56%2.33M-29.56%2.33M-56.52%2.74M71.65%7.36M3.84%5.71M-44.26%3.31M-44.26%3.31M25.24%6.3M-18.39%4.29M
Current deferred liabilities -2.90%805K-4.39%805K-4.39%805K-12.21%805K-9.60%829K-9.60%829K-8.18%842K-8.18%842K0.03%917K0.03%917K
Current liabilities -51.47%6.37M-41.54%8.95M-41.54%8.95M-2.38%11.47M81.85%17.38M5.07%13.13M22.10%15.3M22.10%15.3M6.32%11.75M-31.83%9.56M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -51.47%6.37M-41.54%8.95M-41.54%8.95M-2.38%11.47M81.85%17.38M5.07%13.13M22.10%15.3M22.10%15.3M6.32%11.75M-31.83%9.56M
Shareholders'equity
Share capital 9.41%93K2.35%87K2.35%87K0.00%85K1.19%85K3.66%85K3.66%85K3.66%85K4.43%85K4.69%84K
-common stock 9.41%93K2.35%87K2.35%87K0.00%85K1.19%85K3.66%85K3.66%85K3.66%85K4.43%85K4.69%84K
-Preferred stock --0----------0--0--------------------
Retained earnings -11.47%-388.13M-13.80%-382.45M-13.80%-382.45M-14.85%-372.62M-15.10%-359.38M-15.41%-348.18M-14.67%-336.07M-14.67%-336.07M-14.68%-324.45M-14.94%-312.24M
Paid-in capital 12.12%514.65M4.60%477.23M4.60%477.23M2.04%463.49M2.62%459.05M4.99%459.01M4.92%456.25M4.92%456.25M5.74%454.24M7.35%447.35M
Other equity interest -----------------------------------89K---234K
Total stockholders'equity 14.16%126.62M-21.12%94.87M-21.12%94.87M-29.91%90.96M-26.08%99.76M-18.19%110.92M-15.22%120.26M-15.22%120.26M-11.57%129.78M-7.03%134.96M
Total equity 14.16%126.62M-21.12%94.87M-21.12%94.87M-29.91%90.96M-26.08%99.76M-18.19%110.92M-15.22%120.26M-15.22%120.26M-11.57%129.78M-7.03%134.96M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More